nafenodone has been researched along with desipramine in 1 studies
*Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. [MeSH]
*Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrón, R; Delpón, E; Pérez-Vizcaino, F; Tamargo, J | 1 |
1 other study(ies) available for nafenodone and desipramine
| Article | Year |
|---|---|
Effects of (S)-nafenodone, a new antidepressant, in isolated guinea-pig atrial and ventricular muscle fibres.
Topics: Action Potentials; Animals; Antidepressive Agents; Calcium; Desipramine; Female; Guinea Pigs; Heart; Heart Atria; Heart Ventricles; Imipramine; In Vitro Techniques; Isoproterenol; Lofepramine; Male; Myocardial Contraction; Naphthalenes; Papillary Muscles; Refractory Period, Electrophysiological | 1991 |